Structure of flavones and flavonols. Part I: Role of substituents on the planarity of the system

Computational and Theoretical Chemistry

Volumn 1017, Issue , 2013, Pages 85-90

  Todorova, T Z ^a   Traykov, M G ^b   Tadjer, A V ^a   Velkov, Zh A ^b  

^a UNIVERSITY OF SOFIA   (Bulgaria)

^b SOUTH WEST UNIVERSITY NEOFIT RILSKI   (Bulgaria)

Author keywords

DFT; Flavones; Flavonols; PCM; Structure; Substituents

Indexed keywords

EID: 84879039184     PISSN: 2210271X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.comptc.2013.05.005     Document Type: Article

References (31)

1. Middleton Ell., Kandaswami Ch., Theoharides Th.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52:673-751.
2. Geahlen L.R., Koonchanok M.N., McLaughlin J.L., Pratt D.E. Inhibition of protein-tyrosine kinase activity by flavanoids and related compounds. J. Nat. Prod. 1989, 52:982-986.
3. Masatoshi H., Shigeo I., Toshio T., Kazuo N., Masaaki I., Hiroyoshi H. Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases Biochem. Pharmacology 1988, 37:2987-2992.
4. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 1987, 262:5592-5595.
5. Bolen J.B., Villette A., Schwartz A.M., De-Seau V., Rosen N. Activation of pp 60c-src protein kinase activity in human colon carcinoma. Proc. Natl. Acad. Sci. USA 1987, 84:2251-2255.
6. Salmon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., McGuire W.L. Human breast cancer: correlation of relapse and survival amplification of the HER-2/neu oncogene. Science 1987, 235:177-182.
7. Yamamoto T., Kamata N., Kawano H., Shimizu S., Kuroki T., Toyoshima K., Rikimaru K., Nomura N., Ishizaki R., Pastan I., Gamou S., Shimizu N. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res. 1986, 46:414-416.
8. Calderone V., Chericoni S., Martinelli C., Testai L., Nardi A., Morelli I., Breschi M.C., Martinotti E. Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels. N-S Arch. Pharmacol. 2004, 370:290-298.
9. Hougee S., Sanders A., Faber J., Graus Y.M.F., Berg W.B., Garssen J., Smit H.F., Hoijer M.A. Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages. Biochem. Pharmacol. 2005, 69:241-248.
10. Prasad L., Khan T.H., Jahangir T., Sultana S. Effect of luteolin on nickel chloride-induced renal hyperproliferation and biotransformation parameters in wistar rats. Pharm. Biol. 2007, 45:116-123.
11. Tauber A.I., Fay J.R., MArletta M.A. Flavonoid inhibition of the human neutrophil NADPH-oxidase. Biochem. Pharmacol. 1984, 33:1367-1369.
12. Selloum L., Reichl S., Muller M., Sebihi L., Arnhold J. Effects of flavonols on the generation of superoxide anion radicals by xanthine oxidase and stimulated neutrophils. Arch. Biochem. Biophys. 2001, 395:49-56.
13. Akhlaghi M., Bandy B. Mechanisms of flavonoid protection against myocardial ischemia-reperfusion injury. J. Mol. Cell. Cariol. 2009, 46:309-317.
14. Patra J.C., Chua B.H. Artificial neural network-based drug design for diabetes mellitus using flavonoids. J. Comput. Chem. 2011, 32:555-567.
15. Lee Y.S., Pearlstein R., Kador P.F. Molecular modeling studies of aldose reductase inhibitors. J. Med. Chem. 1994, 37:787-792.
16. Kador P.F., Sharpless N.E. Structure-activity studies of aldose reductase inhibitors containing the 4-oxo-4H-chromen ring system. Biophys. Chem. 1978, 8:81-85.
17. Kador P.F., Sharpless N.E. Pharmacophor requirements of the aldose reductase inhibitor site. Mol. Pharmacol. 1983, 24:521-531.
18. Varma S.D., Kinoshita J.H. Inhibition of lens aldose reductase by flavonoids-their possible role in the prevention of diabetic cataracts. Biochem. Pharmacol. 1976, 25:2505-2513.
19. Rasulev B.F., Abdullaev N., Syrov V.N., Leszczynski J. A quantitative structure-activity relationship (QSAR) study of the antioxidant activity of flavonoids. QSAR Comb. Sci. 2005, 24:1056-1065.
20. Amic D., Davidovic-Amic D., Beslo D., Trinjastic N. Structure-radical scavenging activity relationships of flavonoids. Croat. Chem. Acta 2003, 76:55-61.
21. van Acker S.A.B.E., de Groot M.J., van den Berg D.J., Tromp M.N.J.L., den Kelder G.D.O., van der Vrjgh W.J.F., Bast A. A quantum chemical explanation of the antioxidant activity of flavonoids. Chem. Res. Toxicol. 1996, 9:1305-1312.
22. Velkov Zh.A., Kolev M.K., Tadjer A.V. Modeling and statistical analysis of DPPH scavenging activity of phenolics. Collect. Czech Chem. C 2007, 72:1461-1471.
23. 1ck protein tyrosine kinase. Croat. Chem. Acta 2002, 75:517-529.
24. Aparicio S. A systematic computational study on flavonoids. Int. J. Mol. Sci. 2010, 11:2017-2037.
25. Trouillas P., Fagnere C., Lazzaroni R., Calliste C., Marfak A., Duroux J.L. A theoretical study of the conformational behavior and electronic structure of taxifolin correlated with the free radical-scavenging activity. Food Chem. 2004, 88:571-582.
26. Coleska Z.N., Suturkova L., Dorevski K., Krbavcic A., Solmajer T. Quantitative structure-activity relationship of flavonoid inhibitors of p56lck protein tyrosine kinase: a classical-quantum chemical approach. Quant. Struct. - Act. Rel. 1998, 17:7-13.
27. M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, G. Scal-mani, V. Barone, B. Mennucci, G.A. Peters-son, H. Nakatsuji, M. Caricato, X. Li, H.P. Hratchian, A.F. Izmaylov, J. Bloino, G. Zheng, J.L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J.A.M. Jr., J.E. Peralta, F. Ogliaro, M. Bearpark, J.J. Heyd, E. Brothers, K.N. Kudin, V.N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J.C. Burant, S.S. lyengar, J. Tomasi, M. Coss, N. Rega, J.M. Millam, M. Klene, J.E. Knox, J.B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R.E. Stratmann, O. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W. Ochterski, R.L. Martin, K. Morokuma, V.G. Zakrzewski, G.A. Voth, P. Salvador, J.J. Dannen-berg, S. Dapprich, A.D. Daniels, 'O. Farkas, J.B. Foresman, J.V. Ortiz, J. Cioslowski, D.J. Fox, Gaussian, Inc., Wallingford CT, 2009.
28. Parr R.G., Yang W. Density-functional Theory of Atoms and Molecules 1989, Oxford University Press, Oxford.
29. Nikolic K.M. Theoretical study of phenolic antioxidants properties in reaction with oxygen-centered radicals. J. Mol. Struct. Theochem. 2006, 774:95-105.
30. Riahi S., Norouzi P., Moghaddam Ab.B., Ganjali M.R., Karimipour Gh.R., Sharghi H. Theoretical and experimental report on the determination of oxidation potentials of ihydroxyanthracene and thioxanthens derivatives. Chem. Phys. 2007, 337:33-38.
31. Foresman J.B., Keith T.A., Wiberg K.B., Snoonian J., Frisch M.J. Solvent effects. 5. Influence of cavity shape, truncation of electrostatics, and electron correlation on ab initio reaction field calculations. J. Phys. Chem. 1996, 100:16098.